Since the withdrawal of Vioxx, experts have debated whether other NSAIDs have similar cardiovascular risks

October 2006

Since the withdrawal of Vioxx, experts have debated whether other NSAIDs have similar cardiovascular risks.

Now several new studies are shedding more light.

Vioxx (rofecoxib) seems especially risky...even low doses increase heart attack risk. And this risk is seen shortly after starting the drug...not just after 18 months as originally thought.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote